Navigation Links
Viagra Can Help Prostate Cancer Patients Maintain Sex Lives: Study
Date:10/29/2012

MONDAY, Oct. 29 (HealthDay News) -- Prostate cancer patients who received Viagra before and after their radiation therapy had improved sexual function, according to a new study.

Sexual woes, including erectile dysfunction, are a common side effect of prostate cancer care. The new study included patients with prostate cancer that had not spread who underwent external-beam radiation therapy and/or permanent implantation of radioactive "seeds."

The men were randomly assigned to take either a 50-milligram-a-day dose of Viagra (sildenafil citrate) or an inactive placebo during treatment and for six months after therapy.

The men completed sexual function questionnaires before their first radiation treatment and at six, 12 and 24 months after treatment. The questionnaires asked them about their erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction.

"Men who received the drug showed significantly improved overall sexual function, including improved erectile function," said study lead author Dr. Michael Zelefsky, vice chair for clinical research programs in the department of radiation oncology at Memorial Sloan-Kettering's Cancer Center.

"Results like this are important because they demonstrate that drug therapy used before and after radiation treatment may lessen the risk of impotence, a common side effect of radiation therapy," Zelefsky said in an American Society for Radiation Oncology (ASTRO) news release. Future studies will be needed to further define the drug's role and the optimal duration to prevent loss of sexual function after treatment."

Pfizer, the maker of Viagra, provided partial funding for this study.

One expert said this type of study is valuable for patients.

"Since erectile dysfunction occurs as often with radiation as it does with surgery, this is an important study," said Dr. Warren Bromberg, a urologist at Northern Westchester Hospital in Mount Kisco, N.Y. However, he noted that "while [the researchers'] report an improvement with Viagra compared to placebo, the amount of benefit is not revealed."

Erectile dysfunction medications do have their own issues, Bromberg added, including "the expense of a daily dose of such oral medication, side effects such as facial flushing, headache, stuffy nose, and adverse interactions with other medications."

Still, many prostate cancer patients could benefit, depending on their individual case, Bromberg said. "One difference in how radiation may affect erections compared with surgery is that men who have undergone surgery may see a progressive improvement in their erections for up to 3 years after treatment, whereas men who have undergone radiation may see a progressive decline," he noted. "Therefore, the use of oral medications for men undergoing radiation may be more important in the long run."

The study was to be presented Monday at ASTRO's annual meeting in Boston. Findings presented at medical meetings are typically considered preliminary until published in a peer-reviewed journal.

More information

The Prostate Cancer Foundation has more about erectile dysfunction after prostate cancer treatment.

-- Robert Preidt

SOURCES: Warren Bromberg, M.D., urologist, Northern Westchester Hospital, Mount Kisco, N.Y.; American Society for Radiation Oncology, news release, Oct. 29, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. A Viagra follow-up? Drug used to treat glaucoma actually grows human hair
2. New drug prevents spread of human prostate cancer cells
3. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
4. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
5. Study examines adverse effects among different radiation therapies for prostate cancer
6. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
7. Warren Buffett Has Early Stage Prostate Cancer
8. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
9. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
10. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
11. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viagra Can Help Prostate Cancer Patients Maintain Sex Lives: Study
(Date:12/6/2016)... , ... December 06, 2016 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... audit protocols to understand the scope of their EHS regulatory obligations and rapidly ...
(Date:12/6/2016)... ... 06, 2016 , ... U.S. Security Associates (USA) was named ... their industry leading training methods that engage their associates and link their achievements ... elite in employer-sponsored training and development programs. , “The 2017 Training Top 125 ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... its latest transitional care facility – Avamere Transitional Care of Puget Sound ... foot short-term, post-acute health care center will provide patients recovering from illness or ...
(Date:12/5/2016)... St. Petersburg, Fla. (PRWEB) , ... December 05, 2016 , ... ... effects concussions have on the growing brains of young athletes. Over the course of ... to the head through unique mouth guards. The mouth guards, equipped with special sensors, ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Research and Markets has announced the addition of ... & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, ... to their offering. ... , The western blotting market ... 574.8 Million in 2016, growing at a CAGR of 4.9%. ...
(Date:12/5/2016)... 5, 2016   BIOTRONIK today announced the ... study evaluates the safety and feasibility of performing the ... setting. BioMonitor 2 is an insertable cardiac ... placed underneath a patient,s skin to help physicians accurately ... fibrillation is a leading cause of stroke and heart ...
(Date:12/5/2016)... Dec. 5, 2016  CVS Health, the nation,s largest ... a perfect score of 100 percent on the Corporate ... CEI is an annual national benchmarking survey and report ... administered by the Human Rights Campaign Foundation. ... that our colleagues, customers and suppliers bring to CVS ...
Breaking Medicine Technology: